Ronald Chochinov
Endocrinology, Diabetes & Metabolism · Ventura, CANPI 1730116930
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,600 of the $5,727 with a category attached, or 97.8%. Senseonics, Incorporated accounts for 98.5% of it on its own, with 2 other manufacturers making up the rest.
Across 15 payments — averaging $381.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Senseonics, Incorporated$6K
- Novo Nordisk$65
- Endo Pharmaceuticals Inc.$22
Across 1,940 payments — averaging $1475.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1.8M
- Novo Nordisk AS$744K
- Sanofi US Services Inc.$279K
- Sanofi-aventis U.S. LLC$50K
- Pfizer$11K
What the payments were for
- Speaking & faculty fees$5,60098%
- Food & beverage$621%
- Education$651%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Senseonics, Incorporated | 12 | $5,640 |
| Novo Nordisk | 2 | $65 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Eversense$5,600
How this compares
$5,727 in reported general payments places this provider in the 70th percentile of 952 endocrinology, diabetes & metabolism providers in California.
See all endocrinology, diabetes & metabolism providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Ventura
- Juan FriasSan Diego$1.4M
- Joselito CabaccanSan Jose$1.4M
- Daniel NadeauNewport Beach$1.2M
- Yehuda HandelsmanTarzana$1M
- Helen BaronRancho Mirage$958K
- Ken FujiokaSan Diego$747K
- Minou TranPico Rivera$663K
- James ChuMonterey$639K
- Anthony HeaneyLos Angeles$588K
- Daniel Einhornla Jolla$578K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.